Table 2 Patient characteristics according to presence or absence of ECG abnormalities

From: Electrocardiographic abnormalities and home blood pressure in treated elderly hypertensive patients: Japan home versus office blood pressure measurement evaluation in the elderly (J-HOME-Elderly) study

 

LVH

Abnormal T wave

ST segment depression

 

Absence

Presence

 

Absence

Presence

 

Absence

Presence

 
 

n=631

n=116

P-value

n=606

n=141

P-value

n=704

n=43

P-value

Age (years)

71.5±6.5

71.5±6.6

0.93

71.3±6.3

73.4±6.9

0.0001

71.4±6.4

73.2±7.2

0.07

Women (%)

63.9

58.6

0.28

63.2

62.4

0.86

62.8

67.4

0.54

Body mass index (kg m−2)

23.7±3.1

22.8±2.9

0.008

23.6±3.1

23.4±3.1

0.61

23.6±3.1

23.0±3.1

0.25

Current smoker (%)

8.9

11.2

0.43

9.6

7.8

0.51

9.4

7.0

0.60

Current drinker (%)

23.1

22.4

0.86

23.4

21.3

0.58

23.9

9.3

0.03

Complications

 Diabetes (%)

13.6

13.8

0.96

14.7

9.2

0.09

14.2

4.7

0.08

 Dyslipidemia (%)

39.5

31.9

0.12

38.5

37.6

0.85

38.4

37.2

0.88

 High uric acid (%)

8.7

7.8

0.73

8.4

9.2

0.76

8.7

7.0

0.70

 History of stroke (%)

5.6

3.5

0.35

5.3

5.0

0.88

5.3

4.7

0.86

Morning home

SBP (mm Hg)

133.2±13.3

138.1±17.1

0.004

132.7±13.5

139.3±15.2

<.0001

133.8±14.0

136.9±15.0

0.16

DBP (mm Hg)

77.7±9.1

80.0±0.8

0.03

77.5±9.1

80.3±10.2

0.001

78.1±9.3

76.8±10.4

0.39

HR (b.p.m.)

65.7±8.8

65.5±8.8

0.82

65.9±8.7

64.7±8.8

0.18

65.7±8.7

64.7±9.8

0.50

Evening home

SBP (mm Hg)

127.0±13.6

129.0±15.1

0.16

126.2±13.4

132.2±14.7

<.0001

127.2±13.9

128.7±13.0

0.51

DBP (mm Hg)

72.7±8.6

73.5±9.3

0.38

72.3±8.6

75.0±8.9

0.001

72.9±8.7

72.1±9.5

0.57

HR (b.p.m.)

69.2±8.9

68.8±9.8

0.69

69.3±8.9

68.4±9.6

0.33

69.1±8.9

68.8±10.2

0.83

Office

SBP (mm Hg)

137.4±15.2

141.2±15.3

0.01

137.1±15.2

141.7±15.5

0.001

137.7±15.2

141.5±16.2

0.11

DBP (mm Hg)

77.2±9.0

78.2±9.2

0.27

76.9±9.0

9.3±9.1

0.005

77.4±9.0

77.1±9.9

0.87

HR (b.p.m.)

71.0±9.9

68.8±9.2

0.03

70.8±10.0

69.8±9.0

0.30

70.8±9.8

68.6±9.8

0.17

Duration of hypertension (months)

88.4±94.2

96.9±103.5

0.40

88.7±95.0

93.6±98.8

0.60

88.8±94.6

104.1±112.3

0.33

Number of drug (n)

1.42±0.73

1.37±0.56

0.43

1.43±0.71

1.34±0.68

0.19

1.40±0.70

1.51±0.82

0.34

Antihypertensive treatment (%)

ARB

74.3

78.5

0.35

75.4

73.1

0.56

75.4

67.4

0.24

ACE inhibitor

14.7

14.7

0.98

13.9

18.4

0.17

14.6

16.3

0.77

Diuretics

23.5

17.2

0.14

23.8

17.0

0.08

21.9

32.6

0.10

α-Blocker

9.5

10.3

0.78

9.7

9.2

0.85

9.7

9.3

0.94

β-Blocker

12.0

10.3

0.60

12.2

9.9

0.45

11.5

16.3

0.35

αβ-Blocker

3.2

4.3

0.53

3.5

2.8

0.71

3.4

2.3

0.70

Timing of taking antihypertensive medication (%)

 Morning

91.8

91.4

0.89

90.8

95.7

0.05

91.2

100.0

0.04

 Noon

0.6

0.9

0.78

0.8

0.0

0.28

0.6

2.3

0.17

 Evening

26.5

28.5

0.66

28.6

19.2

0.02

27.1

20.9

0.37

  1. Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; DBP, diastolic blood pressure; ECG, electrocardiography; HR, heart rate; LVH, left ventricular hypertrophy; SBP, systolic blood pressure.
  2. Values are shown as mean±s.d. for continuous variables.